Epidemiology, Diagnosis, and Treatment of HIV-Associated Non-Hodgkin Lymphoma in Resource-Limited Settings

by Matthew Ulrickson, Oliver W. Press, Corey Casper
Published 2012-01-01

Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma.

by Lihua E Budde, Carolina Berger, Yukang Lin, Jinjuan Wang, Xubin Lin, Shani E Frayo, Shaunda A Brouns, David M Spencer, Brian G Till, Michael C Jensen, Stanley R Riddell, Oliver W Press
Published 2013-01-01

Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia model.

by Johnnie J Orozco, Ethan R Balkin, Ted A Gooley, Aimee Kenoyer, Donald K Hamlin, D Scott Wilbur, Darrell R Fisher, Mark D Hylarides, Mazyar Shadman, Damian J Green, Ajay K Gopal, Oliver W Press, John M Pagel
Published 2014-01-01

Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models.

by Sofia H L Frost, Shani L Frayo, Brian W Miller, Johnnie J Orozco, Garrett C Booth, Mark D Hylarides, Yukang Lin, Damian J Green, Ajay K Gopal, John M Pagel, Tom A Bäck, Darrell R Fisher, Oliver W Press
Published 2015-01-01

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies.

by Yawen Li, Donald K Hamlin, Ming-Kuan Chyan, Roger Wong, Eric F Dorman, Robert C Emery, Douglas R Woodle, Ronald L Manger, Margaret Nartea, Aimee L Kenoyer, Johnnie J Orozco, Damian J Green, Oliver W Press, Rainer Storb, Brenda M Sandmaier, D Scott Wilbur
Published 2018-01-01